Linked from

The 154 pages that link to Antimicrobial resistance, each with the reason it gives.

• AntibioticNarrower topic: Bacterial resistance can make infections harder to treat after antibiotic exposure selects resistant variants.

• PlasmidNarrower topic: Plasmids help spread resistance across bacterial populations and species.

• Antibiotic stewardshipNarrower topic: Avoiding unnecessary antibiotic exposure helps slow the selection and spread of resistance.

• Beta-lactamaseNarrower topic: Beta-lactamases are one biochemical route by which bacteria resist antimicrobial drugs.

• Penicillin-binding proteinsNarrower topic: Changes in penicillin-binding proteins are one route bacteria use to resist antibiotics.

• DoxycyclineNarrower topic: Unnecessary doxycycline use contributes selection pressure for resistant bacteria.

• Antibiotic-associated diarrheaNarrower topic: Unnecessary antibiotic treatment can worsen resistance while exposing patients to diarrhea risk.

• Beta-lactam ringNarrower topic: Resistance limits the effectiveness of antibiotics built around this ring.

• SulfonamideNarrower topic: Sulfonamide resistance is one specific instance of this broader clinical problem.

• TrimethoprimNarrower topic: Rising resistance among pathogens can reduce the reliability of trimethoprim treatment.

• CeftriaxoneNarrower topic: Ceftriaxone resistance limits treatment choices and can spread among bacterial populations.

• Multidrug-resistant tuberculosisNarrower topic: MDR-TB is a specific form of resistance to antimicrobial drugs.

• CefazolinNarrower topic: Resistance mechanisms determine which infections cefazolin can reliably treat.

• CeftazidimeNarrower topic: Resistance can erase ceftazidime’s activity and constrain its use against serious infections.

• EthambutolNarrower topic: Using ethambutol alongside other active drugs helps limit selection for resistant tuberculosis bacteria.

• Klebsiella pneumoniaeNarrower topic: Drug resistance can make infections caused by this bacterium difficult to treat.

• MupirocinNarrower topic: Mupirocin resistance is one instance of this broader clinical problem.

• PyrimethamineNarrower topic: Resistance mutations can reduce parasite susceptibility to pyrimethamine.

• Antibiotic use in livestockNarrower topic: Repeated antibiotic exposure in animals selects for this broader public-health problem.

• ClarithromycinNarrower topic: Widespread macrolide resistance has reduced clarithromycin’s reliability for some infections.

• MycobacteriumNarrower topic: Resistance across mycobacterial species complicates treatment and surveillance.

• Tetracycline antibioticsNarrower topic: Resistance has reduced the reliability of tetracyclines against many bacterial strains.

• AmikacinNarrower topic: Amikacin's usefulness depends on preserving its activity as resistant bacteria spread.

• BenzylpenicillinNarrower topic: Resistance mechanisms explain why susceptible bacteria are essential to benzylpenicillin treatment.

• TigecyclineNarrower topic: Tigecycline was developed partly to address tetracycline resistance, but resistance can also emerge to it.

• 4-Aminosalicylic acidNarrower topic: Resistance to tuberculosis drugs creates the need for reserve agents such as PAS.

• CloxacillinNarrower topic: Resistance mechanisms such as altered targets limit cloxacillin’s usefulness.

• OxytetracyclineNarrower topic: Oxytetracycline use can select resistant bacteria in treated hosts and their environments.